Officials in multiple U.S. states are seeking to substantially expand a lawsuit accusing generic-drug companies of colluding to fix prices, including new allegations that high-ranking executives at two companies were directly involved.
from WSJ.com: US Business http://ift.tt/2gZd4bw
via IFTTT
No comments:
Post a Comment